Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019.
Donghee KimBrandon J PerumpailOmar AlshuwaykhBrittany B DennisGeorge CholankerilAndrew A LiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
Hospitalization rates for NAFLD- and ALD-related ESLD increased steadily, while those for HCV-related ESLD decreased during the direct-acting antivirals era.
Keyphrases